Invenra
PrivateLast Round
Debt
Apr 10, 2020
Total Funding Raised
$19.84M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Invenra is a biotechnology company that specializes in the discovery and development of next-generation multispecific antibody therapeutics for oncology and other disease applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Invenra Comparables
Compare Invenra with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tentarix Biotherapeutics | 86% | |
| Adimab | 81% | |
| Radiant Biotherapeutics | 81% |
Invenra Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Apr 10, 2020 | ||||
| Series B | Oct 16, 2018 | ||||
| Series A | Oct 5, 2017 | ||||
| Series A Extension | Jul 20, 2016 | ||||
| Series A Extension | Aug 13, 2015 | ||||
VC Round | Jan 28, 2015 |
Invenra Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rose Ventures Inc. | Series A |
| State of Wisconsin Investment Board | Series B |
| Venture Investors LLC | Series B |
| State of Wisconsin Investment Board (SWIB) | Series B |
| Venture Management, LLC | Series A Extension |
| Wisconsin Investment Partners | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 39% MoM, reaching 4.1K.
- Jun 18, 2026
Monthly visitors increased 125% MoM, reaching 3K.
Invenra Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Invenra's valuation, stock price, and market status.
Is Invenra a public or private company?
Invenra is a private company.
What is the current stock price of Invenra?
Invenra is a private company with no public stock price. No recent secondary market data is available.
How much is Invenra worth (valuation)?
Valuation information for Invenra is not publicly available.
Can I buy Invenra stock?
Invenra shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Invenra's last funding round?
Invenra's most recent funding round was Debt on April 10, 2020.
Who are the main investors in Invenra?
Key investors in Invenra include Venture Investors LLC, Wisconsin Investment Partners.
Will Invenra IPO soon?
No public IPO plans have been announced for Invenra.
How can I track Invenra secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Invenra's secondary market activity and sign up for updates.